Skip to main content
Log in

A rapid chromatographic/mass spectrometric method for digoxin quantification in human plasma

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The relatively simple liquid-liquid extraction LC-MS/MS method using a UPLC column for measurement of digoxin concentrations both in medium and human plasma is described. Digitoxin was used as internal standard. The developed method possesses satisfactory accuracy, precision, and repeatability, and is economical and not time-consuming. It is the first method for precise measurement of digoxin concentrations in human plasma using combined HPLC equipment and UPLC column with a low limit of quantitation equal to 0.1 ng ml – 1 as verified in more than 1500 samples analyzed in a GCP GLP bioequivalence study. The developed method was successfully used in digoxin bioequivalence studies in which 26 volunteers were enrolled.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. Hui, D. R. Geraets, A. Chandrasekaran, et al., J. Clin. Pharmacol., 7, 734 – 741 (1994).

    Google Scholar 

  2. M. C. Tzou, R. A. Sams, R. H. Reuning, J. Pharm. Biomem. Anal., 13, 1531 – 1540 (1995).

    Article  CAS  Google Scholar 

  3. A. Dasgupta, K. T. Yeo, S. Malik, et al., Biochem. Biophys. Res. Commun., 2, 623 – 628 (1987).

    Article  Google Scholar 

  4. A. Sophocleous, I. Elmatzoglou, A. Souvatzoglou, J. Endocrinol. Invest., 7, 668 – 674 (2003).

    Google Scholar 

  5. M. Yoshika, Y. Komiyama, M. Konishi, et al., Hypertension, 49, 209 – 214 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. J. E. Doherty, W. J. Flanigan, M. L. Murphy, et al., J. Sherwood, Circulation, 42, 867 – 873 (1970).

    CAS  Google Scholar 

  7. I. A. de Lannoy, M. Silverman, Biochem. Biophys. Res. Commun., 189, 551 – 555 (1992).

    Article  PubMed  Google Scholar 

  8. C. Verstuyft, M. Schwab, E. Schaeffeler, et al., Eur. J. Clin. Pharmacol., 58, 809 – 812 (2003).

    CAS  PubMed  Google Scholar 

  9. J. H. Zar, Biostatistical Analysis, 2nd Ed., Prentice-Hall, Inc., Englewood Cliffs, New Jersey (1984).

    Google Scholar 

  10. P. Armitage, Statistical Methods in Medical Research, Wiley and Sons, New York (1973).

    Google Scholar 

  11. S. Bolton and C. Bon, Pharmaceutical Statistics: Practical and Clinical Applications, 4th Ed., Revised and Expanded Marcel Dekker ed. (2004), pp. 151 – 172.

  12. Y. Ming, H. Zhang, S. Chong, et al., J. Pharm. Biomed. Anal., 32, 1189 – 1197 (2003).

    Article  Google Scholar 

  13. M. Yao, H. Zhang, S. Chong, et al., J. Pharm. Biomed. Anal., 32, 1189 – 1197 (2003).

    Article  CAS  PubMed  Google Scholar 

  14. W. R. Mathews, D. W. DuCharme, J. M. Hamlyn, et al., Hypertension, 6, 930 – 935 (1991).

    Google Scholar 

  15. H. M. A. M. Qazzaz, R. Valdez, Arch. Biochem. Biophys., 328, 193 – 200 (1996).

    Article  CAS  PubMed  Google Scholar 

  16. Anonymous, Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations, 1 – 21 (2002).

  17. Anonymous, Notice for Industry. Bioequivalence Requirements for Long Half-life Drugs. Health Canada, 1 – 2 (2005).

  18. CDER, Reviewer Guidance Validation of Chromatographic Methods. Food and Drug Administration, Center for Drug Evaluation and Research, Rockville MD (1994).

  19. V. P. Shah, K. K. Midha, S. Dighe, et al., Eur. J. Drug. Metab. Pharmacokinet., 16, 249 – 312 (1991).

    CAS  PubMed  Google Scholar 

  20. ICH, Text on Validation of Analytical Procedures Q2A (1994).

  21. WHO, Use of anticoagulants in diagnostic laboratory investigations, Rev.2 (1999).

  22. CDER, Guidance for Industry Analytical Procedures and Methods Validation. Food and Drug Administration, Center for Drug Evaluation and Research, Rockville MD (2000).

  23. CDER, Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville MD (2001).

  24. EMEA, Note for Guidance on the investigation of bioavailability and bioequivalence, CPMP_EWP_QWP_ 1401_98 (2001).

  25. European Parliament and The Council, Directive 2004_10_EC. Off., J. Europ. Un., 44 – 58 (2004).

  26. P. Kaiser, U. Kramer, D. Meissner, et al., Clin Lab., 49(7 – 8), 329 – 43 (2003).

    CAS  PubMed  Google Scholar 

  27. K. Mitamura, A. Horikawa, Y. Yamane, et al., Biol. Pharm. Bull., 9, 1653 – 1656 (2007).

    Article  Google Scholar 

  28. Y. Hashimoto, K. Shibakawa, S. Nakade, Y. Miyata, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 869(1 – 2), 126 – 32 (2008).

    Article  CAS  Google Scholar 

  29. S. Shi, Z. Li, H. Chen, F. Zeng, J. Chromatogr. B Anal. Technol. Biomed. Life. Sci., 875(2), 405 – 410 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Grabowski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grabowski, T., Świerczewska, A., Borucka, B. et al. A rapid chromatographic/mass spectrometric method for digoxin quantification in human plasma. Pharm Chem J 43, 710–715 (2009). https://doi.org/10.1007/s11094-010-0384-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-010-0384-y

Key words

Navigation